Free Trial

Puma Biotechnology (PBYI) SEC Filings & 10K Form

Puma Biotechnology logo
$2.90 -0.02 (-0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$2.90 +0.00 (+0.17%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Puma Biotechnology SEC Filings

DateFilerForm TypeView
02/14/2025
11:14 AM
ACORN BIOVENTURES, L.P. (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:11 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:34 AM
Camber Capital Management LP (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
02/11/2025
5:55 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:58 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:51 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:53 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:00 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
01/03/2025
6:28 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
6:31 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
6:33 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
6:12 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
7:37 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:30 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:33 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:34 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
11:12 AM
ACORN BIOVENTURES, L.P. (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
11/08/2024
4:31 PM
BlackRock, Inc. (Filed by)
Puma Biotechnology (Subject)
Form SC 13G
11/07/2024
3:40 PM
Puma Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Puma Biotechnology (Subject)
Form SC 13G
09/16/2024
8:01 AM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
8:00 AM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
8:09 PM
MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:27 PM
MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:00 AM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:41 PM
Puma Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:17 PM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
6:06 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
6:11 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
5:50 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
5:57 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
7:35 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
7:36 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
7:39 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
7:43 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
8:19 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:22 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:10 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:15 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:44 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
7:45 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Grab This Altcoin Before Trump's Crypto Announcement (Ad)

Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.

07/02/2024
7:47 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
7:48 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:18 PM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
8:19 PM
MOYES JAY M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:21 PM
MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:22 PM
Puma Biotechnology (Issuer)
Senderowicz Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:25 PM
Puma Biotechnology (Issuer)
Stuglik Brian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:27 PM
Puma Biotechnology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:16 PM
Cesano Alessandra (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:17 PM
Dorval Allison (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:18 PM
Dorval Allison (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:21 PM
MOYES JAY M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:23 PM
Puma Biotechnology (Issuer)
Senderowicz Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:25 PM
Puma Biotechnology (Issuer)
Stuglik Brian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:27 PM
Puma Biotechnology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:41 PM
Dorval Allison (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:42 PM
MOYES JAY M (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:43 PM
Puma Biotechnology (Subject)
Senderowicz Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:44 PM
Puma Biotechnology (Subject)
Stuglik Brian M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:46 PM
Puma Biotechnology (Subject)
WILSON TROY EDWARD (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:41 PM
Puma Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
3:18 PM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
7:10 AM
Puma Biotechnology (Filer)
Form DEF 14A
04/26/2024
7:10 AM
Puma Biotechnology (Filer)
Form DEF 14A
04/26/2024
7:11 AM
Puma Biotechnology (Filer)
Form ARS
04/26/2024
7:11 AM
Puma Biotechnology (Filer)
Form ARS
04/26/2024
7:15 AM
Puma Biotechnology (Filer)
Form DEFA14A
03/29/2024
9:40 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Puma Biotechnology (Subject)
Form SC 13G
03/19/2024
8:01 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PBYI) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners